Australia vs Middle Africa: Proportion of the target population who received a 3rd dose of
Australia
95.0%
in 2024
Middle Africa
56.0%
in 2024
Australia rank
28th
Middle Africa rank
28th
Proportion of the target population who received a 3rd dose of over time
- Australia
- Middle Africa
How they compare
Australia currently reports 95.0% against 56.0% in Middle Africa, a difference of 39.0%.
That makes Australia's figure about 1.7 times Middle Africa's.
Across all 14 years both countries report, Australia has been ahead every year.
Australia ranks 28th and Middle Africa ranks 28th of 157 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Middle Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 92.9% | 44.8% | 48.1% | Australia |
| 2020s | 95.8% | 55.2% | 40.6% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Australia or Middle Africa?
- Australia, at 95.0% against 56.0% in Middle Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Australia and Middle Africa?
- 39.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Middle Africa?
- 14 years are reported by both, from 2011 to 2024.
- How do Australia and Middle Africa rank globally for proportion of the target population who received a 3rd dose of?
- Australia ranks 28th and Middle Africa ranks 28th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.